On the contrary, the detection of TTF-1+/CD56+ CTCs, which represent a minority among the whole population of CTCs since their number was less than that of TTF-1+ or CD56+, further supports the heterogeneity of CTCs in patients with SCLC. Here, TTF1 is linked to small cell lung carcinoma.